Emmitt Smith and Zac Clark promote opioid emergency preparedness on college campuses, emphasizing NARCAN® Nasal Spray education and harm reduction.
Quiver AI Summary
Pro Football Hall of Famer Emmitt Smith and Release Recovery CEO Zac Clark will visit U.S. college campuses to promote opioid emergency preparedness as part of the "Ready to Rescue" campaign by Emergent BioSolutions, relaunched for International Overdose Awareness Day on August 31. This initiative aligns with the Mobilize Recovery's “Campus Surge,” aimed at educating students on opioid overdose responses and the lifesaving use of NARCAN® Nasal Spray. The campaign seeks to combat stigma surrounding opioid emergencies and encourage proactive discussions about mental health and substance use among students. Despite a decline in overdose deaths in 2024, concerns remain, particularly regarding disparities in overdose prevention strategies across states. The events will provide safety kits and demonstrations on recognizing and responding to opioid overdoses, reaffirming Emergent's commitment to fostering awareness and resources for at-risk communities.
Potential Positives
- Emergent BioSolutions is re-launching its Ready to Rescue public education campaign, which could enhance brand visibility and reputation by addressing a critical public health issue, opioid emergencies, among young adults.
- The partnership with high-profile spokesperson Emmitt Smith and Release Recovery's Zac Clark may increase engagement and awareness of the campaign, utilizing their influence to reach a broader audience.
- Emergent's sponsorship of Mobilize Recovery's “Campus Surge” initiative positions the company as a leader in addiction prevention and recovery support in higher education, potentially expanding its network and impact.
- The initiative focuses on educating college students about opioid overdose preparedness and providing life-saving resources, aligning the company's mission to protect and save lives with community health needs.
Potential Negatives
- The press release highlights that despite a general decline in overdose deaths in 2024, the opioid crisis remains a significant issue, implying ongoing challenges for Emergent BioSolutions in addressing public health concerns.
- The need for strong opioid overdose response support in specific states like Texas, Illinois, Louisiana, and Michigan raises questions about the effectiveness of the company's current strategies in combatting the crisis in those areas.
- The mention that less than 15 percent of American college students know how to administer naloxone suggests a significant gap in public awareness and education efforts, indicating potential shortcomings in Emergent's outreach initiatives.
FAQ
What is the Ready to Rescue campaign?
The Ready to Rescue campaign raises awareness about opioid emergencies and promotes the use of NARCAN® Nasal Spray among young adults.
Who are the ambassadors for the campaign?
Pro Football Hall of Famer Emmitt Smith and Release Recovery CEO Zac Clark are the campaign spokespeople.
What events are planned for college campuses?
There will be educational events and tailgates to inform students about opioid overdose preparedness and NARCAN® Nasal Spray demonstrations.
How does the campaign support overdose prevention?
The initiative provides students with resources, conversations, and demonstrations to empower them in recognizing and responding to opioid emergencies.
What impact does opioid misuse have on young adults?
Opioid misuse is highest among young adults aged 18 to 25, with many lacking knowledge on life-saving naloxone medications.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$EBS Insider Trading Activity
$EBS insiders have traded $EBS stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $EBS stock by insiders over the last 6 months:
- NEAL FRANKLIN FOWLER sold 35,000 shares for an estimated $204,050
- KATHRYN C ZOON has made 0 purchases and 2 sales selling 17,086 shares for an estimated $120,152.
- DONALD W DEGOLYER sold 7,844 shares for an estimated $67,830
- KEITH KATKIN sold 7,844 shares for an estimated $49,417
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$EBS Hedge Fund Activity
We have seen 95 institutional investors add shares of $EBS stock to their portfolio, and 99 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 2,525,313 shares (+137.6%) to their portfolio in Q2 2025, for an estimated $16,111,496
- OAK HILL ADVISORS LP added 2,500,000 shares (+224.5%) to their portfolio in Q2 2025, for an estimated $15,950,000
- MILLENNIUM MANAGEMENT LLC removed 1,747,056 shares (-69.8%) from their portfolio in Q2 2025, for an estimated $11,146,217
- QUBE RESEARCH & TECHNOLOGIES LTD removed 740,415 shares (-68.1%) from their portfolio in Q2 2025, for an estimated $4,723,847
- GEODE CAPITAL MANAGEMENT, LLC added 666,708 shares (+108.9%) to their portfolio in Q2 2025, for an estimated $4,253,597
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 605,576 shares (-71.3%) from their portfolio in Q2 2025, for an estimated $3,863,574
- PACER ADVISORS, INC. added 556,730 shares (+inf%) to their portfolio in Q2 2025, for an estimated $3,551,937
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$EBS Analyst Ratings
Wall Street analysts have issued reports on $EBS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 04/01/2025
To track analyst ratings and price targets for $EBS, check out Quiver Quantitative's $EBS forecast page.
Full Release
- Pro Football Hall of Famer and Ready to Rescue campaign spokesperson, Emmitt Smith, and Release Recovery Founder/CEO, Zac Clark, plan to visit several U.S. college campuses to educate on opioid emergency preparedness
- New sponsorship of Mobilize Recovery's “Campus Surge” initiative brings addiction prevention and recovery support to higher education institutions
GAITHERSBURG, Md., Aug. 29, 2025 (GLOBE NEWSWIRE) -- In honor of International Overdose Awareness Day (IOAD) on August 31, Emergent BioSolutions (NYSE: EBS) is re-launching its Ready to Rescue public education campaign, which raises awareness of opioid emergencies and the importance of being prepared with NARCAN ® Nasal Spray among young adults at college/university activations with Greek Life, wellness services and athletic departments. Together, Pro Football Hall of Famer and campaign spokesperson, Emmitt Smith, and Release Recovery founder and CEO, Zac Clark will lead inspiring conversations to break down the stigma around accidental opioid poisonings and empower students to be ready to save a life with over-the-counter NARCAN ® Nasal Spray.
Despite encouraging data showing a decline in overdose deaths in 2024, i the dangers of the opioid crisis remain ever present. A recent report from Mental Health America analyzing publicly available national data shows that progress in reducing overdose deaths is not uniform across the country, with some states differing significantly on prevention strategies and overdose reduction. The report provides a comprehensive ranking of opioid overdose responses across every state, analyzing four systems that have the greatest potential for impact including public health, healthcare, schools and jails.
The new report identifies Texas, Illinois, Louisiana and Michigan as states in need of the most opioid overdose response support in at least one system. This fall, Ready to Rescue will host a tailgate activation at schools near Chicago, IL, and will be joined by Release U – Release Recovery’s digital personal development and mental wellness platform designed to meet the needs of today's students in Dallas, TX, Baton Rouge, LA and Detroit/Ann Arbor, MI. In light of the rise of synthetic opioids, like fentanyl, paired with potential stressors that many students face, ii Smith and Clark will discuss the connection between mental health and substance use, while encouraging students to look out for each other by normalizing these topics. During the events, attendees will also receive Ready to Rescue kits with information on the signs of an opioid emergency and watch NARCAN ® Nasal Spray demonstrations, so they can be prepared to save a life using the simple “Lay, Spray, Stay” method.
"Having personally navigated the profound challenges of opioid dependency after brain surgery and supported so many truly incredible people on their sobriety journeys at Release Recovery, I know that opioid emergencies can happen to anyone, anywhere, at any time,” said Zac Clark, founder & CEO of Release Recovery. “I’m proud to be teaming up with Emergent for these campus events to extend critical naloxone resources that will help the next generation be better prepared in an opioid emergency. Every conversation is an important step in changing the course of the epidemic, and ultimately, saving lives.”
Opioid misuse and dependency is the highest among young adults ages 18 to 25, iii yet less than 15 percent of American college students know how to administer live-saving opioid reversal naloxone medications. iv In honor of IOAD’s focus on overdose prevention and to help close this gap, Emergent is also sponsoring Mobilize Recovery ’s Campus Surge initiative, which will provide action-driven overdose education and harm reduction engagement across several additional college campuses nationwide. This year, Campus Surge will provide life-saving resources and prevention tools to schools at the start of the academic year to empower students to activate change.
“On International Overdose Awareness Day and every day, Emergent honors the countless lives lost from opioid overdoses, and is committed to leading and strengthening our efforts across the U.S. and Canada to help reduce the devastating toll of this public health crisis," said Paul Williams, senior vice president, head of products business, global government & public affairs at Emergent. “Our mission is to protect and save lives – and that is fulfilled when we positively impact at-risk and vulnerable communities, like college students, while also ensuring widespread access and awareness of over-the-counter NARCAN ® Nasal Spray 4 mg, so more people can be ready to rescue when it matters most.”
Recognizing the signs of an opioid overdose/poisoning—such as trouble breathing, pinpoint pupils, and pale and clammy skin—and acting quickly can be the difference between successfully reversing the effects of a poisoning, and not. v Visit ReadytoRescue.com for additional education and resources, and to learn how to be prepared in an opioid overdose emergency with life-saving intranasal naloxone visit NARCAN.com (U.S. site) and NARCANNasalSpray.ca (Canada site).
Emmitt Smith and Zac Clark are paid spokespeople for Emergent.
About NARCAN
®
Nasal Spray
NARCAN
®
Naloxone HCl Nasal Spray 4 mg is the first FDA-approved, over-the-counter (OTC) 4 mg naloxone product for the emergency treatment of opioid overdose. NARCAN
®
Nasal Spray is not a substitute for emergency medical care. Repeat dosing may be necessary. Use as directed.
About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our
website
and follow us on
LinkedIn
,
X
,
Instagram
,
Apple Podcasts
and
Spotify
.
Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
[email protected]
Media Contact:
Assal Hellmer
Vice President, Communications
[email protected]
_____________________________
i
https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2025/20250514.htm
ii
https://americanaddictioncenters.org/rehab-guide/college
iii
https://pmc.ncbi.nlm.nih.gov/articles/PMC8750763/
iv
https://pubmed.ncbi.nlm.nih.gov/38648053/
v
Product Monograph. 2025. NARCAN
®
Nasal Spray. Retrieved from
https://narcannasalspray.ca/PM/NNS_EN.pdf
.
